DOW JONES23,189.97+536.11 2.37%
S&P 5002,716.00+56.59 2.13%
NASDAQ8,033.04+145.78 1.85%

Aerpio Pharmaceuticals Q4 EPS $(0.11) Beats $(0.12) Estimate

Aerpio Pharmaceuticals (NASDAQ:ARPO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 47.62 percent increase over losses of $(0.21) per share

Benzinga · 03/16/2020 12:31

Aerpio Pharmaceuticals (NASDAQ:ARPO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 47.62 percent increase over losses of $(0.21) per share from the same period last year.